title: Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
abstract: Several recent observations have raised the possibility that disturbances in the gut microbiota and/or a low-grade inflammatory state may contribute to symptomatology and the etiology of irritable bowel syndrome (IBS). Consequent on these hypotheses, several therapeutic categories have found their way into the armamentarium of those who care for IBS sufferers. These agents include probiotics, prebiotics, antibiotics, and anti-inflammatory agents.
authors.affiliation: Department of Medicine, Alimentary Pharmabiotic Centre, Cork University Hospital, University College Cork, Clinical Sciences Building, Cork, Ireland. e.quigley@ucc.ie
authors.forename: Eamonn M M
authors.initials: EM
authors.lastname: Quigley
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000382:microbiology* / Q000503:physiopathology / Q000628:therapy*; D056692:Prebiotics; D019936:Probiotics / Q000627:therapeutic use*; D058616:Synbiotics
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D056692:Prebiotics